Editorial: On the threshold of a changed EU
Biopeople is a cluster organization with strong ties to Europe. We have several cluster based collaborations in the EU, and we expect UK life science clusters to become an important part of our collaborative network. It will, however, be interesting to see how the UK referendum results might affect our plans and the opportunities we see in a closer relation between Danish and UK life science.
This spring the Boost4Health voucher program was launched. This program is a cluster collaboration program of the North West Europe with participation of the UK, North West Germany, Holland, Belgium, France, Spain and Denmark. This program is a follow up on previous voucher programs as Facilis and In2Life Sciences and the UK is represented for the first time and with two cluster organizations – the presence of the UK is a very positive part of the project.
Part of our plans regarding Danish-British collaboration around life science and SME’s, is also a closer collaboration with the British life science based Catapult centers facilitated by UK Trade and Investment at the British Embassy in Copenhagen.
The centers are a network of world-leading centers designed to transform the UK’s capability for innovation in specific areas and help drive future economic growth. Among eleven centers are three life science based centers - the Cell and Gene Therapy Catapult, which will grow UK cell and gene therapy industry, delivering health and wealth; a Medicines Discovery Catapult, which is the center of national expertise for the discovery of medicines. This center was established as a private sector, industry focused, independent organization to develop new approaches for the discovery and early development of new medicines helping to transform ideas into commercial products and services. Finally the Precision Medicine Catapult is focused on making the UK the most compelling location in the world for the development and delivery of this new targeted approach.
Biopeople is in contact with the Precision Medicine Catapult and the Cell and Gene Therapy Catapult. At a recent seminar on Precision Medicine at the British Embassy in Copenhagen a speaker from the Precision Medicine Catapult was part of the agenda. Furthermore Biopeople and the Cell and Gene Therapy Catapult have taken the initial steps to arrange a seminar in Copenhagen in collaboration with UK Trade and Investments.
We do not hope that the EU referendum results will influence our valuable contact and plans with the UK life science community. We hope to expand the contact we have established for the mutual benefit of sharing knowledge and experience cross borders.
Have a nice summer